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Abstract
Background: Preconception care, including family planning, is a vital component of healthcare for women of
reproductive age. An average female spends the majority of her reproductive life trying to prevent a pregnancy. In
order to prevent unintended pregnancy, women often rely on the use of hormonal contraceptives. In the United
States, the majority of hormonal contraceptive users are prescribed oral contraceptive pills (OCPs). Reduced adherence
to OCPs decreases their ability to prevent pregnancy. The study aimed to measure OCP adherence among female
college students, and explore the relationship between OCP adherence, knowledge, and self-efficacy.
Methods: This cross-sectional study recruited a random sample of female college students to participate in an online
survey. OCP adherence was based on the 8-item Morisky Medication Adherence Scale (MMAS-8). Secondary reporting
of medication adherence included participant reports of the number of missed OCP doses in the previous month and
typical month of use.
Results: Of the 5000 invited, 1559 (31.3%) completed the survey. Of those responding, 670 (41.3%) reported use of
OCPs. A total of 293 (44.3%) OCP users met criteria for low adherence, 241 (36.4%) met criteria for medium adherence,
and 128 (19.3%) met criteria for high adherence. Those with high adherence had higher self-efficacy (P < 0.001) and
perceived knowledge (p < 0.001). After controlling for other factors, self-efficacy (b = .37) and perceived knowledge
(b = .09) remained associated with OCP adherence.
Conclusion: Less than 20% of respondents met the criteria for high adherence to OCPs. Self-efficacy and knowledge
were associated with higher OCP adherence. Targeted interventions from healthcare providers, health educators, and
other adherence related media to increase the knowledge and self-efficacy of patients using OCPs may improve
adherence rates. Additional research is needed to evaluate the impact of innovative interventions focused on social
and behavioral patient factors, like knowledge and self-efficacy, on adherence to OCPs.
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Plain English summary
A large portion of women rely upon oral contraceptive
pills (OCPs) as a part of their family planning strategy.
For OCPs to work effectively at preventing pregnancies,
women must consistently take them. In other words,
OCPs require good adherence. In this study women
attending college at one university were recruited to
answer questions in an online survey to detect any prob-
lems with OCP adherence, and determine if self-efficacy
or knowledge influence OCP adherence.
The women that participated in the online survey were
asked if they used OCPs. Those who used OCPs were
asked about their self-efficacy, or feeling that they could
confidently take their birth control correctly, knowledge
of their OCP, and adherence in taking their OCP. In
addition, the women in this study provided their age, re-
lationship status, reason for OCP use, and past use of
emergency contraception.
A total of 670 women, or just over 40% of those in this
study, used OCPs. Over 50% of these women missed at
least one dose of their OCP in the month prior to the
survey. Adherence to OCPs was related to both self-
efficacy and knowledge.
In sum, there is room to improve OCP adherence in
women attending college. Increasing knowledge about
OCPs and building self-efficacy may be effective strat-
egies to improve OCP adherence.
Background
Preconception care, including family planning, is a vital
component of healthcare for women of reproductive
age. Unsuccessful pregnancy prevention efforts have the
potential to lead to unintended pregnancies. The conse-
quences of an unintended pregnancy, which include
those that were mistimed and unwanted, include im-
pacts to the fetus, the mother, and society. Fetal impacts
include a delay in receiving necessary prenatal supple-
ments, potential for exposure to environmental risks
(including alcohol, nicotine, or other drugs), and in-
creased potential for birth defects and low birth weight
[1]. Additionally, children resulting from unintended
pregnancies have been shown to experience poor mental
and physical health and have lower educational attain-
ment and more behavioral health issues in their teens
[2]. Mothers of unintended pregnancies have been
shown to be at increased risks of adverse effects from
delays in prenatal care, maternal depression, and reduc-
tion in income potential [3]. Lastly, a significant burden
has been placed on society by unintended pregnancies.
Estimates suggest that unintended pregnancies cost the
United States $21 billion in 2010, which includes the
cost of births, abortions, and miscarriages from
unintended pregnancies [4].
Although only 8% of U.S. women report unmet family
planning needs and 99.1% of sexually active women
report having used some form of contraceptive, there
remains significant disparities in pregnancy prevention
[5, 6]. Prior to 2011 there had been nearly no change
over the last 30 years in pregnancies that were reported
as unintended when conceived (49%) or births that were
reported to be unintended (37%) [7–9]. This is particu-
larly troubling, as the availability of contraceptives has
improved over this same timeframe [9]. Although these
rates dropped in 2011 to 45% and 36%, respectively,
there remains a considerable concern over the high un-
intended rate and the prevention of unintended preg-
nancy continues to be a key focus of the public health
system in the United States [1].
Consistent and correct use of modern contraception
has a dramatic impact on unintended pregnancies. Only
68% of women that are at risk for an unintended preg-
nancy report correct and consistent use of contracep-
tion, and these women account for only 5% of
unintended pregnancies [10]. Estimates suggest that
non-adherence may be directly the cause of approxi-
mately 20% of unintended pregnancies each year [11].
For oral hormonal contraceptives (also known as “the
pill” or oral contraceptive pill, OCP), perfect use requires
users to take every dose within the same 4-h window
each day. Those who are not able to maintain perfect
use, or are non-adherent to their contraception method
of choice, reduce the effectiveness rates considerably
[11]. Perfect adherence has been shown to prevent
nearly all unintended pregnancies (<1% failure rate),
compared to a nearly 9% failure rate with typical use
(i.e., inconsistent or incorrect use) [12, 13].
In this study, less than perfect adherence is referred
to as poor adherence, or nonadherence. Past estimates
of OCP nonadherence range from 25% not taken
within the “window of hormonal safety” [14], to ap-
proximately 33–52% of women missing 1 or more pill
per cycle [12, 15–17], with over 20% missing 2 or
more pills per cycle [16]. Even in an oral contracep-
tive clinical trial, the rate of nonadherence (labelled
noncompliance in the study) was 17% [18]. It is
important to consider potential causes of non-
adherence and interventions that may appropriately
target these causes.
Previous research has suggested a number of factors
associated with poor OCP adherence, but the research is
limited overall [19–21]. Previously identified correlates
of OCP adherence include the establishment of a pill
taking routine, information seeking habits, and race and
ethnicity [19, 20]. In addition, one study showed higher
levels of patient reported perceived behavioral control
and the presence of coping strategies for non-adherence
were positively associated with adherence to OCPs [21].
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Given the limited data regarding influential factors of
OCP adherence, this study aims to investigate several
possible determinants. The primary objectives of this
study are to: 1) determine self-reported adherence to
OCPs based upon a validated measure, 2) explore
demographic differences in adherence rates, 3) exam-
ine the relationship between self-efficacy and perceived
knowledge on adherence.
Methods
This cross-sectional research was conducted using an
online survey platform, Qualtrics®. The survey was
electronically distributed to participants using their
preferred email. The online survey platform allowed
complex skip patterns and flow logic to be employed,
whereby a respondent’s earlier choice in the survey de-
termined the question displayed, and also the specific
OCP product referenced in the question. Participants
not currently using any form of hormonal contracep-
tive were directed to answer a separate set of questions
designed to gather basic demographics, involvement in
risky behaviors, and method of pregnancy prevention
used. The University of Minnesota and Chapman
University Institutional Review Boards approved this
study.
Participants
This study was conducted at the University of
Minnesota, a public research university in the
Midwestern United States with approximately 50,000
thousand enrolled students, of which over 25,000 are
female. A simple random sample of 5000 female stu-
dents was obtained from the University of Minnesota’s
Office of Institutional Research. This sample was lim-
ited to the list of degree-seeking females with full-time
enrollment status aged 18 and older. Students who had
suppressed their contact information were excluded
from the panel. A total of 5000 email invitations were
sent to potential participants, 14 of which were
returned as undeliverable. One reminder e-mail was
sent 7 days after the initial e-mail to selected individ-
uals that had not yet responded. In sum, 1750 individ-
uals opened the survey, 1623 consented to participate,
and 1559 completed the survey. The survey comple-
tion rate of invited individuals who received the invita-
tion email was 31.3% (1559/4986). Only those taking
OCPs were included in the analyses below (n = 670).
Measures
OCP Adherence
Adherence to OCPs was measured using the 8-item
Morisky Medication Adherence Scale (MMAS-8) [22].
This scale is extensively used in survey research as a
proxy for medication adherence, and has shown
concurrent validity with non-humanistic markers of
adherence [22–25]. The items in the scale ask partici-
pants questions about their medication-related behav-
iors and causal indicators, for example, “Do you
sometimes forget to take your oral contraceptive?” The
first seven items have a yes/no response format. The
final item, “How often do you have difficulty remem-
bering to take your oral contraceptive?” A five-item
Likert scale was used to measure item 8.. Items were
summed to provide a continuous measure of self-
reported adherence ranging from 0 to 8, with higher
scores indicating higher adherence. No participants
had missing data on more than one MMAS-8 item,
thus all met the 75% eligibility criterion for the scale.
Per standard scoring procedures, missing data on
MMAS-8 items were imputed by using the median
value from those participants who met the eligibility
criteria. Cut points were used to categorize high (sum
score = 8), medium (sum score 6 to <8), and low (sum
score < 6) adherence based on previously established
categories [22]. In the original study of patients with
high blood pressure, high adherence was associated
with blood pressure control, which further demonstrated
the criterion-related validity of the MMAS-8 in measuring
adherence [22]. In order to compare the present findings
to prior studies, we also asked how many days participants
forgot to take their OCP in a typical month, and then
more specifically last month. Response options were
Never, 1 time per month, 2–3 times per month, 4–5 times
per month, and 6 or more times per month. Self-report of
missed doses was used to describe the sample, and
compared by adherence category.
Correlates of OCP Adherence
Perceived knowledge of OCP being used was measured
using one item. Perceived knowledge is defined here as
a self-assessment of knowledge, or in other words,
what each respondent thinks they know about their
OCP. Participants were asked: How would you rate
your knowledge of your hormonal contraceptive, on a
scale from 1 to 10, where 1 means “I know nothing”
and 10 means “I know everything.” Responses were
recoded to be grounded at zero (i.e., ranging from 0 to
9), with a higher score equating to higher perceived
knowledge. Self-efficacy of using OCP correctly was
measured with one item. Here, self-efficacy is defined
as the belief that one can successfully perform a behav-
ior [26], namely in this study, correctly use her OCP.
We measured self-efficacy by asking individuals to in-
dicate their level of agreement on a 5-point Likert-type
scale with the statement “I feel confident that I use my
contraceptive correctly.” The responses were coded
from 0 (‘Strongly Disagree’) to 4 (‘Strongly Agree’).
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Covariates
Participants reported their age, relationship status, rea-
son for OCP use, and past emergency contraceptive
use. Age was collected as a continuous variable. Partic-
ipants indicated their current relationship status, and
we dichotomized responses as in a committed relation-
ship (married, committed dating relationship, engaged)
or not in a committed relationship (single, separated,
widowed, divorced). Participants were asked to report
the reasons why they were using OCP (i.e., pregnancy
prevention, help regulate menses, reduce symptoms as-
sociated with menses, improving acne, treatment of
premenstrual dysphoric disorder, or other), which was
used to create a new variable dichotomized by those
indicating that pregnancy prevention was one of the
reasons they were using OCP (1), and those that did
not (0).
Statistical analysis
We first examined the descriptive statistics for all
study variables. To examine potential differences in
participant characteristics and bivariate relationships
between study variables, we used ANOVA for continu-
ous variables and chi square test for categorical vari-
ables. The alpha value for statistical significance was
set at 0.05, with a Bonferroni correction applied for
comparisons of continuous variables between adher-
ence categories. We used ordinary least squares regres-
sion to determine the relationship between perceived
knowledge, self-efficacy, and medication adherence
after controlling for age, relationship status, and use of
OCP for pregnancy prevention. List-wise deletion of
cases with missing data resulted in 650 total observa-
tions for regression analysis.
Results
The overall sample contained 670 OCP users (41.9%),
228 other contraceptive users (14.3%), and 700 non-
users (43.8%). Of the OCP users, 293 (44.3%) met cri-
teria for low adherence, 241 (36.4%) met criteria for
medium adherence, and 128 (19.3%) met criteria for
high adherence (Table 1). The mean score for OCP
users’ reported knowledge of their OCP was 6.03
(scored from 0 to 9), signifying a potential knowledge
gap. Conversely, a majority of participants reported
higher rates of self-efficacy, with a mean score of 3.43
(scored 0 to 4). Additional participant data and demo-
graphic characteristics are shown in Table 1.
Table 2 provides a comparison of demographics and
correlates of adherence by OCP adherence category.
Significant differences were found between groups for
relationship status (P = 0.016), with the proportion in a
relationship highest among the high adherence group.
There were significant differences in perceived knowledge
(P < 0.001) and perceived self-efficacy (P < 0.001). The low
adherence group had significantly lower perceived
knowledge compared to the medium (P = 0.002) and high
(P < 0.001) adherence groups. Additionally, the low ad-
herence group had significantly lower perceived self-
efficacy compared to the medium and high groups
(P < 0.001 for both), and the medium group had
significantly lower self-efficacy than the high group
(P = 0.028).
Results of ordinary least squares regression are
shown in Table 3. After controlling for age, relation-
ship status, and use of OCP for pregnancy prevention,
Table 1 Demographic characteristics of participants using OCPs
Mean/% (S.D.)
Age 21.95 (4.1)
Years in college 3.42 (2.1)
Relationship status
In a relationship 61.2%
Not in a relationship 38.8%
Primary reason(s) for using hormonal contraceptiona
Pregnancy prevention 84.6%
Regulation of menses 71%
Reduce symptoms associated with menses 52.7%
Improving acne 35.4%







Typical month missed doses
Never 37.8%
1 time per month 39.6%
2–3 times per month 18.6%
4–5 times per month 2.7%
6 or more times per month 1.2%
Last month missed doses
Never 46.9%
1 time per month 31.2%
2–3 times per month 17.9%
4–5 times per month 3.3%
6 or more times per month 0.8%
Mean perceived knowledge (range 0 to 9) 6.03 (1.5)
Mean perceived self-efficacy (range 0 to 4) 3.43 (0.6)
aParticipants could select multiple responses; OCPs oral contraceptive pills;
S.D. standard deviation
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perceived knowledge (beta = .08; P = .032) and self-
efficacy (beta = .37; P < .001) were both positively re-
lated to OCP adherence scores using the MMAS-8.
The R2 of the regression model was 0.16.
Discussion
This study determined the rate of OCP adherence, ex-
plored demographic differences in adherence rates, and
examined the relationship between self-efficacy and per-
ceived knowledge on adherence for a sample of women
enrolled at a large Midwest university. According to the
MMAS-8, 80.7% of OCP users exhibited some degree of
non-adherence, or in other words less than perfect ad-
herence, higher than past estimates of non-adherence to
OCPs [12–18]. The report of missed doses in an aver-
age/typical month in this study was also higher than pre-
viously reported estimates (62% reported missing at least
1 dose per month, compared to 33–52% reported in
previous research [12, 15–17]).
Several differences were noted between adherence
groups when categorized by the MMAS-8. While there
was no difference in age, years in college, or use of OCP
for pregnancy prevention, a higher proportion of those
in the high adherence group reported being in a rela-
tionship. This latter finding is consistent with other
research demonstrating that women in consistent rela-
tionships are more likely to use effective contraception
when compared to women in casual relationships [27].
As expected, proportionally fewer individuals in the high
adherence group reported missing 2 or more doses in
both a typical month and last month, and the high ad-
herence group exhibited a higher mean perceived know-
ledge and higher mean perceived self-efficacy when
compared to the low adherence group.
After controlling for demographic factors, perceived
knowledge and self-efficacy remained positively related
to OCP adherence. These findings, while cross-sectional,
suggest that knowledge and self-efficacy could be useful
targets for future interventional research focused on im-
proving OCP adherence. This is supported by prior work
that has shown the amount of accompanying educa-
tional material read and understood was related to ad-
herence [19]. Additionally, a study by Molloy and
colleagues established the relationship between per-
ceived behavioral control, a concept similar to self-
efficacy, and medication adherence among OCP users
[21]. These findings in OCP adherence are consistent
with a cadre of prior literature that established the rela-
tionship between self-efficacy on medication adherence
for other disease states [28, 29].
Table 2 Demographic characteristics and correlates of adherence by OCP adherence category
Low adherence Medium adherence High adherence P
Overall (%) 44.3% 36.4% 19.3% n/a
Age (mean)a 21.8 21.9 22.4 .346
Years in college (mean)a 3.4 3.3 3.6 .559
In a relationship (%)B 55.9% 61.7% 71.9% .009
OCP for pregnancy prevention (%)b 84.2% 84.2% 87.5% .652
Perceived knowledge (mean)a 5.74 6.18 6.40 <.001
Perceived self-efficacy (mean)a 3.21 3.54 3.71 <.001
2 or more missed pills typical monthb 45.9% 5.8% 0.8% <.001
2 or more missed pills last monthb 42.7% 8.3% 0% <.001
aANOVA
bchi-square test
Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A Licensure agreement is available from: Donald E. Morisky, ScD, ScM, MSPH,
Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young Drive South, Los Angeles, CA
90095–1772, dmorisky@ucla.edu
Table 3 Results of ordinary least squares regression of OCP adherence score
Unstandardized coefficient (B) Standard error Standardized coefficient (beta) P
Constant 2.45 .46 .000
Age .00 .01 −.02 .641
In a relationship .19 .12 .06 .116
OCP for pregnancy prevention −.06 .16 −.01 .725
Perceived knowledge .09 .04 .08 .032
Perceived self-efficacy .93 .10 .37 .000
Model adjusted R2 .16
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Current recommendations for counseling adolescents
about contraception include assessment of self-efficacy
toward a contraceptive method [30]. This recommenda-
tion is also shared within the CDC’s and U.S. Office of
Population Affairs’ family planning recommendations,
which recommends that the provider evaluates potential
barriers to continued appropriate use of the contracep-
tion being considered [31]. These recommendations en-
courage the provision of counseling services to improve
patient knowledge, but also highlight the importance of
evaluating social-behavioral factors, including patient
confidence in ability to use consistently and correctly
[31]. Our findings support these recommendations.
Limitations
Although this study provides insight on factors influen-
cing OCP adherence, the findings must be placed in
context of the limitations. First, the use of a cross-
sectional method to collect data does not allow causality
to be inferred from the results. In addition, the method-
ology employed in this study could lead to volunteer
bias, and potential recall bias. Use of the MMAS-8 has
historically focused on measuring adherence to medica-
tions related to chronic or long-term infectious condi-
tions, and though OCP use is similar to other chronic
medications (i.e. medication must be taken daily), it is
unclear if the MMAS is the most appropriate medication
adherence scale to use. Previous research has shown the
ability to tailor the MMAS-8 to unique disease states
and dosage forms, such as, asthma inhalants, injectable
insulins for diabetes, and oral osteoporosis medications
dosed less frequently than daily [32]. In this study, self-
report of missed doses was related to the MMAS-8 ad-
herence categories, providing evidence for its use in
OCP research. Further research and modification to the
original scale may be warranted to develop an optimal
scale. This study’s cohort had a higher education level
compared to the general population in the U.S., limiting
the generalizability of these findings to the overall U.S.
population. It is concerning that in this highly educated
sample such high levels of missed OCP doses were
found. Lastly, the measures of perceived knowledge and
self-efficacy used in this study were single-item indica-
tors. While these indicators could be helpful clinical
tools in terms of ease of administration, answers do not
specifically indicate what knowledge is lacking or what
elements of self-efficacy are low. This limits the ability
to more specifically examine possible reasons for OCP
nonadherence, and design interventions to remedy these
gaps. However, low perceived knowledge or self-efficacy
reported by a patient could prompt a clinician to delve
into tailored counseling to ameliorate knowledge gaps
and improve self-efficacy.
Conclusion
Based upon the adherence measure used, only 20% of the
women in this study met criteria for a high level of OCP
adherence. The findings from multivariable analysis af-
firms the relationship between self-efficacy and perceived
knowledge on OCP adherence. We are not aware of any
other study that has linked perceived knowledge of OCPs
to OCP adherence. These findings highlight the import-
ance of patient knowledge and self-efficacy and the need
to target these factors to improve adherence. Healthcare
practitioners, health educators, and other adherence re-
lated media may need to consider focusing their attention
to efforts aimed at ensuring proper patient knowledge and
a better sense of self-efficacy in managing OCP use. More
research is necessary to determine the best measure of
OCP adherence and effective approaches to improve self-
efficacy and knowledge of patients to their OCP.
Additionally, future research needs to measure the impact
of these approaches on adherence to OCPs and reduction
in unintended pregnancies.
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